Chronic lymphocytic leukemia (CLL) is characterized by the expansion of monoclonal CD5+/CD23+ B lymphocytes in the peripheral blood, bone marrow, and secondary lymphatic tissues [1]. Here, FCER2 is linked to B-cell chronic lymphocytic leukemia.